Suppr超能文献

石莼中岩藻甾醇的抗糖尿病活性

Anti-diabetic activities of fucosterol from Pelvetia siliquosa.

作者信息

Lee Yeon Sil, Shin Kuk Hyun, Kim Bak-Kwang, Lee Sanghyun

机构信息

Seokwon Life Science Research Institute, World Sea Green Co Ltd, Paju 413-832, Korea.

出版信息

Arch Pharm Res. 2004 Nov;27(11):1120-2. doi: 10.1007/BF02975115.

Abstract

Fucosterol isolated from Pelvetia siliquosa was tested for its anti-diabetic activity in vivo. Fucosterol, when administered orally at 30 mg/kg in streptozotocin-induced diabetic rats, was caused a significant decrease in serum glucose concentrations, and exhibited an inhibition of sorbitol accumulations in the lenses. Fucosterol, when administered orally at 300 mg/kg in epinephrine-induced diabetic rats, was also caused an inhibition of blood glucose level and glycogen degradation. These results demonstrated that fucosterol is a main anti-diabetic principle from the marine algae P. siliquosa.

摘要

对从海带中分离得到的岩藻甾醇进行了体内抗糖尿病活性测试。在链脲佐菌素诱导的糖尿病大鼠中,以30mg/kg的剂量口服岩藻甾醇,可使血清葡萄糖浓度显著降低,并抑制晶状体中山梨醇的积累。在肾上腺素诱导的糖尿病大鼠中,以300mg/kg的剂量口服岩藻甾醇,也可抑制血糖水平和糖原降解。这些结果表明,岩藻甾醇是海藻海带中的主要抗糖尿病成分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验